Elantas Beck Q1FY27: standalone PAT jumps 80% YoY as margins expand sharply
PAT +80.4% YoY · revenue +35% · margins expanding
₹283.39 Cr
+35% YoY
₹70.86 Cr
+80.4% YoY
23.41%
+6.2pp YoY
₹89.39
Standalone revenue for the quarter ended June 30, 2026 came in at ₹283.39 Cr, up 35.0% YoY from ₹209.93 Cr and 27.6% QoQ from ₹222.17 Cr in Q4 FY26. Net profit surged 80.4% YoY to ₹70.86 Cr (₹39.29 Cr a year ago) and 128.0% QoQ, with EPS at ₹89.39 versus ₹49.56 a year earlier. Profit growing well ahead of revenue signals margin expansion rather than pure volume-led growth. No consensus estimates or brokerage previews for this stock turned up in a web search, consistent with it being a small, thinly covered specialty-chemicals name — vsStreet is unknown, not a miss.
Q1 FY-2027 vs prior quarters
The margin gain traces to input costs: cost of materials consumed fell to 58.5% of revenue from 63.1% a year ago (₹165.81 Cr on ₹283.39 Cr revenue versus ₹132.46 Cr on ₹209.93 Cr), while employee costs (+7.0% YoY) and other expenses (+5.6% YoY) grew far slower than the 35% topline gain, producing clear operating leverage. EBITDA margin (PBT plus depreciation and finance costs, excluding other income) expanded to roughly 28.8% from 18.9% YoY and 19.5% QoQ; net margin on total income rose to 23.4% from 17.2% YoY. Both segments contributed: Electrical Insulations revenue grew 30.2% YoY with segment profit up 110.6%, while Engineering & Electronic Resins and Materials grew revenue 56.5% YoY with profit up 79.7% — Insulations delivered the larger absolute profit gain. The company has no formal guidance on record and no prior concall commentary in our archive, so there is no outlook to grade this print against; the filing's accompanying letter carries only the standard board-meeting outcome, with no separate management commentary to quote.
The stock went into the print at ₹9,730.1, down 1.2% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.
Capex intensity has stepped up alongside the print — the company committed ₹56 Cr toward a Gujarat plant capacity expansion (announced June 2, 2026), and half-year PP&E/intangible purchases already rose to ₹49.05 Cr from ₹17.40 Cr a year earlier, with capital work-in-progress up to ₹14.06 Cr from ₹8.22 Cr at December-end. Separately, the company appointed M S K A & Associates as statutory auditors in May 2026, who issued the review report on this filing. The long-running Ankleshwar (Gujarat) plant closure matter flagged by the state pollution board remains open, with the temporary revocation valid only until October 3, 2026, pending a permanent resolution.
W1
Raw-material cost ratio (58.5% of revenue this quarter, down from 63.1% YoY) — watch whether this holds as input prices normalize
W2
₹56 Cr Gujarat capacity expansion execution — H1FY27 PP&E purchases already at ₹49.05 Cr vs ₹17.40 Cr YoY
W3
GPCB Ankleshwar closure-order outcome — temporary revocation expires October 3, 2026, permanent revocation request still pending
Only standalone results filed (no consolidated statement). EPS is basic=diluted, not annualised, per company note. No exceptional-items line in the P&L, so no adjustment needed to YoY PAT growth. OPM/EBITDA margin computed as (PBT + depreciation + finance costs − other income) / revenue from operations to match the historical NPM/OPM convention supplied in context.